Your browser doesn't support javascript.
loading
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer.
Nishimura, Kazuki; Nishio, Kyosuke; Hirosuna, Kensuke; Komura, Kazumasa; Hayashi, Takuo; Fukuokaya, Wataru; Ura, Ayako; Uchimoto, Taizo; Nakamura, Ko; Fukushima, Tatsuo; Yano, Yusuke; Takahashi, Nobushige; Nakamori, Keita; Kinoshita, Shoko; Matsunaga, Tomohisa; Tsutsumi, Takeshi; Tsujino, Takuya; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Takahara, Kiyoshi; Inamoto, Teruo; Hirose, Yoshinobu; Kimura, Takahiro; Egawa, Shin; Azuma, Haruhito.
Afiliação
  • Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nishio K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Hirosuna K; Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan kazumasa.komura@ompu.ac.jp.
  • Hayashi T; Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Fukuokaya W; Department of Human Pathology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Ura A; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Uchimoto T; Department of Human Pathology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Nakamura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Fukushima T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Yano Y; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Takahashi N; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Kinoshita S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Matsunaga T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Tsutsumi T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Taniguchi K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Tanaka T; Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Uehara H; Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Takahara K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Inamoto T; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan.
  • Hirose Y; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Kimura T; Department of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Egawa S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Azuma H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
J Immunother Cancer ; 10(1)2022 01.
Article em En | MEDLINE | ID: mdl-35039462
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article